0 Ratings
ID

31183

Description

Study ID: 104505 Clinical Study ID: BEX104505 Study Title: Phase II Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00950755 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin Please record all concomitant medications and transfusions from the time of study entry through the Week 13 visit. Include study-required medications (i.e. Lugol's solution or potassium iodide, paracetamol, and diphenhydramine).

Keywords

Versions (1)
  1. 7/25/18 7/25/18 -
Copyright Holder

see clinicaltrials.gov

Uploaded on

July 25, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Iodine 131 B1 Antibody for B-Cell Lymphomas NCT00950755

    English

    Concomitant Medications & Transfusions

    1 forms  
    Administrative Data
    Description

    Administrative Data

    Alias
    UMLS CUI-1
    C1320722
    Site Number
    Description

    Site number

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C0018704
    UMLS CUI [1,2]
    C0600091
    Patient Number
    Description

    Patient Number

    Data type

    text

    Alias
    UMLS CUI [1]
    C1830427
    Patient Initials
    Description

    Patient Initials

    Data type

    text

    Alias
    UMLS CUI [1]
    C2986440
    Concomitant Medications; Concomitant Transfusions
    Description

    Concomitant Medications; Concomitant Transfusions

    Alias
    UMLS CUI-1
    C2347852
    Drug Name or Blood Product
    Description

    Concomitant Agent; Drug Name or Blood Product

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C2360065
    UMLS CUI [1,3]
    C0456388
    Dose
    Description

    Concomitant Agent; Dose

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C3174092
    Unit
    Description

    Concomitant Agent; Unit

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C1519795
    Route
    Description

    Concomitant Agent; Route

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C0013153
    Frequency
    Description

    Concomitant Agent; Frequency

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C3476109
    Start Date
    Description

    Concomitant Agent; Start Date

    Data type

    date

    Alias
    UMLS CUI [1]
    C2826734
    End Date
    Description

    Concomitant Agent; End Date

    Data type

    date

    Alias
    UMLS CUI [1]
    C2826744
    Back to the top of the page

    Similar models

    Concomitant Medications & Transfusions

    1 forms
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    Administrative Data
    C1320722 (UMLS CUI-1)
    Site number
    Item
    Site Number
    text
    C0018704 (UMLS CUI [1,1])
    C0600091 (UMLS CUI [1,2])
    Patient Number
    Item
    Patient Number
    text
    C1830427 (UMLS CUI [1])
    Patient Initials
    Item
    Patient Initials
    text
    C2986440 (UMLS CUI [1])
    Item Group
    Concomitant Medications; Concomitant Transfusions
    C2347852 (UMLS CUI-1)
    Concomitant Agent; Drug Name or Blood Product
    Item
    Drug Name or Blood Product
    text
    C2347852 (UMLS CUI [1,1])
    C2360065 (UMLS CUI [1,2])
    C0456388 (UMLS CUI [1,3])
    Concomitant Agent; Dose
    Item
    Dose
    text
    C2347852 (UMLS CUI [1,1])
    C3174092 (UMLS CUI [1,2])
    Concomitant Agent; Unit
    Item
    Unit
    text
    C2347852 (UMLS CUI [1,1])
    C1519795 (UMLS CUI [1,2])
    Concomitant Agent; Route
    Item
    Route
    text
    C2347852 (UMLS CUI [1,1])
    C0013153 (UMLS CUI [1,2])
    Concomitant Agent; Frequency
    Item
    Frequency
    text
    C2347852 (UMLS CUI [1,1])
    C3476109 (UMLS CUI [1,2])
    Concomitant Agent; Start Date
    Item
    Start Date
    date
    C2826734 (UMLS CUI [1])
    Concomitant Agent; End Date
    Item
    End Date
    date
    C2826744 (UMLS CUI [1])
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial